Trader: Novo Nordisk's third-quarter results exceeded expectations and raised performance guidelines. The stock price is expected to rise by 3-4%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.